Company: INDP
Filing Date: 2025-09-02
Form Type: 424B5
Source: 0001493152-25-012530
Chunk: 55

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-09-02
Form: 424B5
Chunk 55
---
 securities will be separately transferable;                                    |
| ● | information with respect                                                                                                        
 to book-entry procedures, if any;                                                                                               |
| ● | material Israeli and United                                                                                                     
 States federal income tax consequences, if any;                                                                                 |
| ● | the anti-dilution provisions                                                                                                    
 of the warrants, if any; and                                                                                                    |
| ● | any other terms of such                                                                                                         
 warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.                   |

The description in the applicable prospectus supplement of any warrants we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable warrant agreement and warrant certificate, which will be filed with the SEC if we offer warrants. For more information on how you can obtain copies of the applicable warrant agreement and warrant certificate if we offer warrants, see “Where You Can Find More Information” and “Incorporation of Certain Documents by Reference”. We urge you to read the applicable warrant agreement and warrant certificate and any applicable prospectus supplement in their entirety.

| 26 |

<div align='center'>DESCRIPTION OF UNITS</div>

We may issue units comprised of one or more of the other securities that may be offered under this prospectus, in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately at any time, or at any time before a specified date.

The prospectus supplement relating to any units we offer will, to the extent applicable, include specific terms relating to the offering, including some or all of the following:

| ● | the material terms of the                                                                                                        
 units and of the securities comprising the units, including whether and under what circumstances those securities may be held or 
 transferred separately;                                                                                                          |
| ● | any material provisions                                                                                                          
 relating to the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and  |
| ● | any material provisions                                                                                                          
 of the governing unit agreement that differ from those described above.                                                          |

The description in the applicable prospectus supplement of any units we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable unit agreement, which will be filed with the SEC if we offer